Davis Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Davis Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-9	Closed	-$283	–	1218
2026 Q2	$283	Buy	+9	New	+$266	﹤0.01%	744

Other funds holding CPRX

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Davis Capital Management's CPRX Position: Q3 2026 in Review

Davis Capital Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 9 shares — an estimated $283 sold.

Davis Capital Management first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $283 in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

Davis Capital Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Davis Capital Management sold 9 Catalyst Pharmaceutical shares in Q3 2026, an estimated $283.
Davis Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
Davis Capital Management's Catalyst Pharmaceutical position peaked at $283 in Q2 2026.
2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.